Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Novo Nordisk markets its semaglutide drugs as Ozempic pre-filled pen and Rybelsus oral tablet ... Lilly’s market cap is around $700 billion while NVO’s market cap is around $281 billion.

Merilog has been cleared in a 3ml single-patient-use prefilled pen, and a 10ml multiple-dose ... of a mandatory $35 monthly insulin copay cap for Medicare. While a few years ago, the loss of ...

FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...

With the incredible weight loss associated with new drugs such as Ozempic and Mounjaro, a whole host of unwanted health side effects have been seen too - one being 'Ozempic mouth'. Others include ...

Recent reports highlight a growing number of Ozempic users experiencing changes in their foot appearance and comfort due to rapid weight loss. A significant reduction in body fat can lead to ...

Ozempic and other weight loss drugs could have a gnarly side effect dubbed “Ozempic-feet,” according to a report. The popular pound-shedding prescription drug is known to cause several ...